Multidisciplinaire richtlijn Cardiovasculair ... - Diliguide

Chen JD, Cheng TJ, Lin YC, Hsiao ST. Job categories and acute ischemic heart disease: a
hospital-based, case-control study in Taiwan. Am J Ind Med 2007;50:409-14.
Choi HK, Hernan MA, Seeger JD, Robins JM, Wolfe F. Methotrexate and mortality in patients
with rheumatoid arthritis: a prospective study. Lancet 2002;359:1173-7.
Chorus AM, Van Overbeek K, Hopman-Rock M. Reumatische klachten in Nederland.
Resultaten Nationale Peiling van het Bewegingsapparaat 2006. Utrecht: NIVEL; 2007.
Claxton AJ, Cramer J, Pierce C. A systematic review of the associations between dose regimens
and medication compliance. Clin Ther 2001;23:1296-310.
Clement DL, De Buyzere ML, De Bacquer DA, De Leeuw PW, Duprez DA, Fagard RH, et al.
Prognostic value of ambulatory blood-pressure recordings in patients with treated
hypertension. N Engl J Med 2003;348:2407-15.
Cleophas TJ. Wine, beer and spirits and the risk of myocardial infarction: a systematic review.
Biomed Pharmacother 1999;53:417-23.
Colditz GA, Bonita R, Stampfer MJ, Willett WC, Rosner B, Speizer FE, et al. Cigarette
smoking and risk of stroke in middle-aged women. N Engl J Med 1988;318:937-41.
Colhoun HM, Betteridge DJ, Durrington PN, Hitman GA, Neil HA, Livingstone SJ, et al.
Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the
Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebocontrolled
trial. Lancet 2004;364:685-96.
Collins R, Peto R, MacMahon S, Hebert P, Fiebach NH, Eberlein KA, et al. Blood pressure,
stroke, and coronary heart disease. Part 2, Short-term reductions in blood pressure:
overview of randomised drug trials in their epidemiological context. Lancet 1990;335:827-
38.
Conroy RM, Pyorala K, Fitzgerald AP, Sans S, Menotti A, De BG, et al. Estimation of ten-year
risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 2003;24:987-
1003.
Cooper AR, Moore LA, McKenna J, Riddoch CJ. What is the magnitude of blood pressure
response to a programme of moderate intensity exercise? Randomised controlled trial
among sedentary adults with unmedicated hypertension. Br J Gen Pract 2000;50:958-62.
Corona A. Statin therapy and infection-related mortality. Crit Care Med 2007;35:1635-6.
Costa G. Shift work and occupational medicine: an overview. Occup Med (Lond) 2003;53:83-
8.
Critchley J, Capewell S. Smoking cessation for the secondary prevention of coronary heart
disease. Cochrane Database Syst Rev 2004;CD003041.
Dahlof B, Devereux RB, Kjeldsen SE, Julius S, Beevers G, De Faire U, et al. Cardiovascular
morbidity and mortality in the Losartan Intervention For Endpoint reduction in
hypertension study (LIFE): a randomised trial against atenolol. Lancet 2002;359:995-1003.
Dahlof B, Sever PS, Poulter NR, Wedel H, Beevers DG, Caulfield M, et al. Prevention of
cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril
as required versus atenolol adding bendroflumethiazide as required, in the Anglo-
MULTIDISCIPLINAIRE RICHTLIJN CARDIOVASCULAIR RISICOMANAGEMENT 114